Corticosteroid Bruising

Open Access
Publisher Website
Google Scholar
Abstract
Over the period of a year, 58 patients receiving long-term corticosteroid therapy for rheumatoid arthritis and ankylosing spondylitis have been examined repeatedly for evidence of pathological bruising. Of 40 receiving exogenous corticosteroids, 60% had pathological bruising and of 18 receiving corticotrophin none was so affected. The pathological bruising of long-term exogenous corticosteroid therapy can be a serious complication. (It is hoped that the above findings may provide a clue to its remedy.).

This publication has 2 references indexed in Scilit: